The Evidence-Based Guide to Antipsychotic Medications
View Pricing
Description
The Evidence-Based Guide to Antipsychotic Medications is designed to provide both clinicians and residents with focused, comprehensive, and clinically relevant information regarding the use of antipsychotic medications to treat a broad range of psychiatric conditions—from mood and anxiety disorders to substance abuse, personality disorders, and schizophrenia.
The volume editor is a renowned psychiatrist and author with more than 25 years of experience in both clinical and research settings diagnosing and treating patients with mood and psychotic disorders. In addition, each of the volume's 13 contributors is an expert with many years of clinical experience to draw on.The book is down-to-earth and reader-friendly and is structured for maximal utility in both coverage and format:
- Key Clinical Points cap each chapter, synthesizing and summarizing the knowledge you can take away, and serving both as a refresher for those using the book as a reference and as a study aid to master the material.
- Both FDA-approved and off-label use of antipsychotic medications are addressed, reflecting the reality of clinical practice on the front lines.
- Use of antipsychotic medications in both the pediatric and geriatric populations, a potentially controversial subject, is addressed in a nonsensational, straight-forward manner.
- The Appendixes provide a wealth of information in tabular format, including drug tables (names, strengths, formulations, pharmacokinetics, and dosing); advice on initiating and monitoring antipsychotic medications; common side effects and their management; and special considerations for use during pregnancy and breastfeeding.
The Evidence-Based Guide to Antipsychotic Medications is the first in a new series that strives to take evidence-based psychiatry from gold standard to standard practice. Scientifically up-to-date and rigorous, yet accessible and easy to understand, this volume stands alone as an indispensable resource on the topic.
Contents
- Contributors
- Acknowledgments
- Disclaimer
- Chapter 1. Introduction
- Chapter 2. Schizophrenia and Schizoaffective Disorder
- Chapter 3. Mood and Anxiety Disorders
- Chapter 4. Personality Disorders
- Chapter 5. Substance Abuse Disorders
- Chapter 6. Use of Antipsychotics in Children and Adolescents
- Chapter 7. Use of Antipsychotics in Geriatric Patients
- Chapter 8. Use of Antipsychotics in Medically Ill Patients
- Appendix 1: Names, Strengths, and Formulations of First- and Second-Generation Antipsychotics
- Appendix 2: Pharmacokinetics of First- and Second- Generation Antipsychotics
- Appendix 3: Dosing and Administration of First- and Second-Generation Antipsychotics in Schizophrenia
- Appendix 4: Medical Workup When Initiating and Continuing First- and Second-Generation Antipsychotics
- Appendix 5: Medical Workup When Initiating and Continuing Clozapine
- Appendix 6: Use of First- and Second-Generation Antipsychotics for Agitation Due to Psychosis
- Appendix 7: Side Effects of Commonly Used Antipsychotics
- Appendix 8: Management of Treatment-Emergent Side Effects of Antipsychotic Medications
- Appendix 9: Use of First- and Second-Generation Antipsychotics in Pregnancy and Lactation
- Index
Contributors
- Kristina M. Deligiannidis, M.D.
David F. Gitlin, M.D.
Gerardo Gonzalez, M.D.
Michael D. Jibson, M.D., Ph.D.
Charles Madeira
Bruce Meltzer, M.D.
Ruben Miozzo, M.D., M.P.H.
Jayendra K. Patel, M.D.
Anthony J. Rothschild, M.D.
Kenneth R. Silk, M.D.
Marcus W. Tjia, M.D.
Ellen M. Whyte, M.D.
Douglas Ziedonis, M.D., M.P.H.
About the Authors
Anthony J. Rothschild, M.D., is Irving S. and Betty Brudnick Endowed Chair and Professor of Psychiatry in the Department of Psychiatry at University of Massachusetts Medical School and UMass Memorial Healthcare in Worcester, Massachusetts.
Related Products
Carousel Control - items will scroll by tabbing through them, otherwise arrows can be used to scroll one item at a time